Briefing Materiai
for 1s*quarter ended Mar. 31, 2026
May 14, 2026
NAKANISHI INC.
Disclaimer
The information presented in these materials contains forward-looking statements about future
business performance. These statements by definition involve risks and uncertainties and are not intended to guarantee future performance. Actual results in the future may differ from expectations and the projections presented in these materials due to changes in the global economy and fluctuations in foreign currency exchange rates and so on.
2026 NAKANI SHI INC.
Dental Business
Development, production and sales of wide range of dental equipment, which cover such as restorative dentistry, periodontics, oral surgery, mobile dental care, etc.
DCI Business
Handpiece
Implant motor
Oral hygiene system
Clinical micro motor
Presenting results of DCI, acquired in 2023, as an independent segment.
Development, production and sales of dental chairs and related equipment for the North American market.
Surgical Business
Development, production and sales of bone grinding and cutting drills which can be used in areas of neurosurgery, spine surgery and orthopedic surgery.
The results of Acra Cut and Intech (acquired in 2026) are included in this Surgical Business.
Industrial Business
Development, production and sales of spindles which can be used in high-precision processes in wide range of industrial areas such as automobile and precision parts industries.
Console
Controller & Spindle
Dental chair
Surgical motor & Attachment
Speed-increasing spindle
Dental cabinet
Bur (Disposable)
Ultrasonic cutter
Dental parts
Perforator (Disposable)
Tools
A
chieved double-digit sales growth across all segments; Dental, DCI, Surgical, and Industrial. In particular, sales grew in Dental-Japan and Surgical businesses.
Consolidated net sales increased by 21% YoY, and by 15% even excluding forex impact.
A
*The Q1 financial results do not include the performance of the two acquired companies (Acra Cut and Intech). They are expected to be consolidated from Q2 onward.
Ithough increased production at factories led to an improvement in the standalone gross margin, the consolidated gross margin declined by 2 percentage points due to
the impact of unrealized profits and U.S. tariffs. In addition to profit growth driven by higher revenues, the partial underspending of certain R&D plan resulted in consolidated EBITDA increasing by 23.6OoYoY.
n addition to operating profit growth driven by business expansion, improvements in foreign exchange gains and losses and the absence of the previous year's impact of
prior-period income taxes led to a significant increase in quarterly profit attributable to owners of parent.
FY2026Q1
FY2025Q1
YoY comparison
Actual | Actual | Amount | Ratio | |
Net sales | 22,488 | 18,542 | +3,946 | +21.3% |
Gross Profit | 12,935 | 11,076 | +1,858 | +16.8% |
Ratio to net sales | 57.5% | 59.7% | -2.2pt | |
EBITDA | 5,876 | 4,755 | +1,120 | +23.6% |
Margin | 26.1 % | 25.6% | +0.5pt | |
Operating Profit | 4,675 | 3,361 | +1,313 | +39.1% |
Ratio to net sales | 20.8% | 1 8.1 % | +2.7pt | |
Ordinary Profit | 5,548 | 2,626 | +2,921 | +1 1 1.2% |
Ratio to net sales | 24.7% | 1 4.2% | +1 0.5pt |
Profit attributable to owners of parent
3,980
440
+3,539
+803.9%
Ratio to net sales | 1 7.7% | 2.4% | +1 5.3pt | |||
E | P | S | (JPY) | 47.93 | 5.23 | |
4 EBITDA = Operating profit + Depreciation + Amortization | ||||||
Currency rate | - Against the US dollar (JPY) | 156.48 | 152.95 | +3.53 | ||
- Against the EURO (JPY) | 183.73 | 160.74 | +22.99 | |||
Forex impact: Net sales +1,031 M of JPY (vs FY2025Q 1 Actual), +1,050M of JPY (vs FY202d Forecast)
5
6 NAKANISHI INC.